Regeneron Pharma (REGN) PT Lowered to $810 at Guggenheim
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $806.85 +1.11%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
Guggenheim analyst Yatin Suneja lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $810.00 (from $940.00) while maintaining a Buy rating.
You May Also Be Interested In
- Resideo Technologies (REZI) PT Lowered to $27 at Oppenheimer
- Medipal Holdings Corp (7459:JP) PT Lowered to JPY3,080 at Nomura/Instinet
- STAAR Surgical (STAA) PT Lowered to $28 at Jefferies
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
